rxstat › Shortages › Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol

Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol products are in shortage in Canada (2 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 / 10
In shortage since
May 5, 2026
Reports on file
24
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TRI-CIRA 28
0.035MG 0.035MG 0.215MG 0.25MG 0.035MG 0.18MG · TABLET · APOTEX INC
DIN 02508095 · since May 5, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TRI-CIRA 21
0.035MG 0.18MG 0.25MG 0.035MG 0.215MG 0.035MG · TABLET · APOTEX INC
DIN 02508087 · since May 5, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
TRI-JORDYNA 21
0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02486296 · ended Jun 19, 2026 · Demand increase for the drug.
Resolved
TRI-JORDYNA 28
0.035MG 0.18MG 0.035MG 0.215MG 0.035MG 0.25MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02486318 · ended Jun 5, 2026 · Demand increase for the drug.
Resolved
TRI-JORDYNA 28
0.035MG 0.18MG 0.035MG 0.215MG 0.035MG 0.25MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02486318 · ended Apr 9, 2026 · Demand increase for the drug.
Resolved
TRI-CIRA LO 21
0.18MG 0.025MG 0.025MG 0.25MG 0.025MG 0.215MG · TABLET · APOTEX INC
DIN 02401967 · ended Aug 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TRI-CIRA 21
0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG · TABLET · APOTEX INC
DIN 02508087 · ended Feb 1, 2024 · Disruption of the manufacture of the drug.
Resolved
TRI-CIRA 28
0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG · TABLET · APOTEX INC
DIN 02508095 · ended Aug 11, 2023 · Disruption of the manufacture of the drug.
Resolved
TRI-CIRA 21
0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG · TABLET · APOTEX INC
DIN 02508087 · ended Aug 11, 2023 · Disruption of the manufacture of the drug.
Resolved
TRI-CIRA LO 21
0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG · TABLET · APOTEX INC
DIN 02401967 · ended Apr 13, 2023 · Delay in shipping of the drug.
Resolved
TRI-CIRA 21
0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG · TABLET · APOTEX INC
DIN 02508087 · ended Mar 15, 2023 · Delay in shipping of the drug.
Resolved
TRI-CIRA LO 21
0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG · TABLET · APOTEX INC
DIN 02401967 · ended Mar 4, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 24 reports. All reports are on file with Health Canada.

What's happening

Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Norgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Partial shortageDrospirenone Ethinyl Estradiol1 of 9 reported products affected · est. return Aug 10, 2026Partial shortageEthinyl Estradiol Desogestrel1 of 10 reported products affected · est. return Aug 20, 2026Partial shortageEthinyl Estradiol Levonorgestrel3 of 18 reported products affectedPartial shortageEthinyl Estradiol Levonorgestrel Ethinyl Estradiol1 of 1 reported products affectedPartial shortageEthinyl Estradiol Norethindrone4 of 10 reported products affected · est. return Mar 19, 2027Partial shortageNorethindrone1 of 4 reported products affected · est. return Aug 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.